Progresif keratokonus için etkili bir tedavinin iki yıllık sonuçları: hızlandırılmış epi-on korneal çapraz bağlama

Yıl 2024, Cilt: 17 Sayı: 4, 764 - 772, 09.10.2024

Muhammet Kaim , Murat Okutucu , Hüseyin Fındık , Feyzahan Uzun

https://doi.org/10.31362/patd.1460362

Öz

Amaç: Korneal kollajen çapraz bağlama (CXL), progresif keratokonus için cerrahi bir tekniktir. Farklı klinik sonuçlara sahip çeşitli teknik modifikasyonları vardır. Bu çalışmada, hızlandırılmış epitelyum-on CXL'nin uzun vadeli sonuçlarını değerlendirmeyi amaçladık.
Gereç ve yöntem: Hızlandırılmış epitelyum-on CXL ile tedavi edilen ve 24. ay takibini tamamlayan progresif keratokonus hastaları üzerinde retrospektif bir çalışma yaptık. 77 hastanın 111 gözünü dahil ettik. Görme keskinliği, aberrometri, topografik ölçümler ve kırma kusurları gibi klinik değişkenleri cerrahi sonrası 12. ve 24. aylarda değerlendirdik.
Bulgular: Hastaların %50,4'ünde ameliyat sonrası görme keskinliğinde anlamlı artış görüldü (p<0,001). 12. ay ve 24. ay takiplerinde belirlenen Baiocchi Calossi Versaci total indeksi ve alt düşük dereceli aberasyon değerleri, başlangıç değerlerinden anlamlı derecede yüksekti (p=0,044 ve p=0,033). Ön kamara derinliği, ön kamara hacmi, ön apikal keratometri ve gözbebeğinin ortalama gücü, 12. ve 24. ay değerlendirmelerinde başlangıç değerlerine göre anlamlı derecede düşüktü (p<0,05). 12. ay değerlendirmesinde santral kornea kalınlığında (p=0,043) ve arka apikal keratometride (p=0,034) başlangıç değerlerine göre anlamlı artışlar tespit edildi. Horizontal ön kamara çapı (p=0,005) ve keratokonus alanı (p=0,001) 24. ay değerlendirmesinde ameliyat öncesine göre anlamlı olarak farklıydı.
Sonuç: Çalışma bulguları, hızlandırılmış epitelyum-on CXL’in görme keskinliğini önemli ölçüde artırdığını ve hastalığın progresyonunu durdurduğunu gösterdi. Böylece, hızlandırılmış epitelyum-on CXL’in, progresif keratokonusun cerrahi tedavisinde modifiye CXL yöntemleri arasında iyi bir seçenek olduğu ortaya konuldu.

Anahtar Kelimeler

Aberometri, görme keskinliği, Epi-on korneal çapraz bağlama, keratokonus, korneal topografi

An effective treatment for progressive keratoconus with two-year outcomes: accelerated epithelium-on corneal cross-linking

Öz

Purpose: Corneal collagen cross-linking (CXL) is a surgical technique for progressive keratoconus. There are several technical modifications with varying clinical outcomes. This study aimed to evaluate the long-term outcomes of the accelerated epithelium-on CXL.
Materials and methods: A retrospective study was performed on progressive keratoconus patients treated via the accelerated epithelium-on CXL who completed the 24th-month follow-up. We included 111 eyes of 77 patients. Clinical variables, including visual acuity, aberrometry, topographic measurements, and refractive outcomes, were evaluated at the postoperative 12th and 24th months.
Results: There was a significant improvement in postoperative visual acuity in 50.4% of patients (p<0.001). Baiocchi Calossi Versaci total index and lower low-order aberration values determined at the 12th-month and 24th-month follow-up visits were significantly higher than the baseline values (p=0.044 and p=0.033). The depths of the anterior chapter and its aqueous part, the anterior chamber volume, front apical keratometry, and the mean power of the pupil were significantly lower in the 12th and 24th-month evaluations than the baseline values (p<0.05). For the 12th-month evaluation, significant increments in the central corneal thickness (p=0.043) and back apical keratometry (p=0.034) were detected than the baseline values. The horizontal anterior chamber diameter (p=0.005) and the keratoconus area (p=0.001) were significantly different in the 24th-month evaluation than in the preoperative period.
Conclusion: The study findings indicated that accelerated epithelium-on CXL stabilized disease progression and significantly improved visual acuity. Therefore, accelerated epithelium-on CXL stands out as one of the better options among the modified CXL techniques to treat progressive keratoconus surgically.

Anahtar Kelimeler

Aberrometry, corneal topography, epithelium-on corneal cross-linking, keratoconus, visual acuity

Kaynakça

• 1. Knutsson KA, Genovese PN, Paganoni G, et al. Evaluation of a post-operative therapy protocol after epithelium-off corneal cross-linking in patients affected by keratoconus. J Clin Med 2022;11:7093. https://doi.org/10.3390/jcm11237093
• 2. Mohebbi M, Samavat B, Mohammadi A. One-year non-comparative observational study to evaluate corneal tomographic, densitometric, and aberrometric features following accelerated corneal cross-linking in progressive keratoconus. Int Ophthalmol 2023;43:1721-1735. https://doi.org/10.1007/s10792-022-02572-3
• 3. Borchert GA, Watson SL, Kandel H. Oxygen in corneal collagen crosslinking to treat keratoconus: A systematic review and meta-analysis. Asia Pac J Ophthalmol 2022;11:453-459. https://doi.org/10.1097/APO.0000000000000555
• 4. Ang MJ, Darbinian JA, Hoskins EN, Holsclaw DS, Sudesh S, Chandra NS. The safety profile of fda-approved epithelium-off corneal cross-linking in a us community-based healthcare system. Clin Ophthalmol 2022;16:1117-1125. https://doi.org/10.2147/OPTH.S359224
• 5. Wajnsztajn D, Shmueli O, Zur K, Frucht Pery J, Solomon A. Predicting factors for the efficacy of cross-linking for keratoconus. PLoS One 2022;17:e0263528. https://doi.org/10.1371/journal.pone.0263528
• 6. Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. J Cataract Refract Surg 2009;35:1358-1362. https://doi.org/10.1016/j.jcrs.2009.03.035
• 7. Ferdi AC, Kandel H, Nguyen V, et al. Five-year corneal cross-linking outcomes: a save sight keratoconus registry study. Clin Exp Ophthalmol 2023;51:9-18. https://doi.org/10.1111/ceo.14177
• 8. Vaidya NS, Daneshmand A, Epstein RJ, et al. Pachymetric assessment after EpiSmart® epithelium-on cross-linking for keratoconus and post-surgical ectasia. Clin Ophthalmol 2022;16:1829-1835. https://doi.org/10.2147/OPTH.S359710
• 9. D'Oria F, Palazón A, Alio JL. Corneal collagen cross-linking epithelium-on vs. epithelium-off: a systematic review and meta-analysis. Eye Vis 2021;8:34. https://doi.org/10.1186/s40662-021-00256-0
• 10. Li Y, Lu Y, Du K, et al. Comparison of efficacy and safety between standard, accelerated epithelium-off and transepithelial corneal collagen crosslinking in pediatric keratoconus: a meta-analysis. Front Med 2022;9:787167. https://doi.org/10.3389/fmed.2022.787167
• 11. Stock RA, Brustollin G, Mergener RA, Bonamigo EL. Efficacy of standard and accelerated (10 minutes) corneal crosslinking in keratoconus stabilization. Clin Ophthalmol 2020;14:1735-1740. https://doi.org/10.2147/OPTH.S258205
• 12. Kandel H, Nguyen V, Ferdi AC, et al. Comparative efficacy and safety of standard versus accelerated corneal crosslinking for keratoconus: 1-year outcomes from the save sight keratoconus registry study. Cornea. 2021;40:1581-1589. https://doi.org/10.1097/ICO.000000000000274
• 13. Atalay E, Najjar RP, Tun TA, Özalp O, Bilgeç MD, Yıldırım N. Corneal elevation changes after forced eyelid closure in healthy participants and in patients with keratoconus. Clin Exp Optom 2019;102:590-595. https://doi.org/10.1111/cxo.12891
• 14. Ziaei M, Gokul A, Vellara H, Patel D, McGhee CNJ. Prospective two year study of changes in corneal density following transepithelial pulsed, epithelium-off continuous and epithelium-off pulsed, corneal crosslinking for keratoconus. Cont Lens Anterior Eye 2020;43:458-464. https://doi.org/10.1016/j.clae.2020.03.004
• 15. Kır MB, Türkyılmaz K, Öner V. Transepithelial high-intensity cross-linking for the treatment of progressive keratoconus: 2-year outcomes. Curr Eye Res 2017;42:28-31. https://doi.org/10.3109/02713683.2016.1148742
• 16. Arance Gil Á, Villa Collar C, Pérez Sanchez B, Carracedo G, Gutiérrez Ortega R. Epithelium-off vs. transepithelial corneal collagen crosslinking in progressive keratoconus: 3 years of follow-up. J Optom 2021;14:189-198. https://doi.org/10.1016/j.optom.2020.07.005
• 17. Ouyang BW, Ding H, Wang H, et al. Comparison of corneal biological parameters between transepithelial and epithelium-off corneal cross-linking in keratoconus. Int J Ophthalmol 2021;14:998-1005. https://doi.org/10.18240/ijo.2021.07.06
• 18. Nawaz S, Gupta S, Gogia V, Sasikala NK, Panda A. Trans-epithelial versus conventional corneal collagen crosslinking: a randomized trial in keratoconus. Oman J Ophthalmol 2015;8:9-13. https://doi.org/10.4103/0974-620X.149855
• 19. Kamiya K, Kanayama S, Takahashi M, Shoji N. Visual and topographic improvement with epithelium-on, oxygen-supplemented, customized corneal cross-linking for progressive keratoconus. J Clin Med 2020;9:3222. https://doi.org/10.3390/jcm9103222
• 20. Nath S, Shen C, Koziarz A, et al. Transepithelial versus epithelium-off corneal collagen cross-linking for corneal ectasia: a systematic review and meta-analysis. Ophthalmology 2021;128:1150-1160. https://doi.org/10.1016/j.ophtha.2020.12.023
• 21. Ng SM, Ren M, Lindsley KB, Hawkins BS, Kuo IC. Transepithelial versus epithelium-off corneal crosslinking for progressive keratoconus. Cochrane Database Syst Rev 2021;3:CD013512. https://doi.org/10.1002/14651858.CD013512.pub2
• 22. Ng SM, Hawkins BS, Kuo IC. Transepithelial versus epithelium-off corneal crosslinking for progressive keratoconus: Findings from a cochrane systematic review. Am J Ophthalmol 2021;229:274-287. https://doi.org/10.1016/j.ajo.2021.05.009
• 23. Yuksel E, Cubuk MO, Yalcin NG. Accelerated epithelium-on or accelerated epithelium-off corneal collagen cross-linking: contralateral comparison study. Taiwan J Ophthalmol 2020;10:37-44. https://doi.org/10.4103/tjo.tjo_11_19
• 24. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 2003;135:620-627. https://doi.org/10.1016/s0002-9394(02)02220-1
• 25. Farhat R, Ghannam MK, Azar G, et al. Safety, efficacy, and predictive factors of conventional epithelium-off corneal crosslinking in the treatment of progressive keratoconus. J Ophthalmol 2020;2020:7487186. https://doi.org/10.1155/2020/7487186
• 26. Latif K, Iqbal MS. Visual and topographical outcomes following accelerated trans-epithelial corneal crosslinking in progressive keratoconus. J Coll Physicians Surg Pak 2017;27:552-555.
• 27. Aldairi W, AlQahtani R, Alzaid S, Mousa A, Khandekar R, Al Swailem SA. Accelerated versus conventional corneal collagen crosslinking: short-term clinical outcomes in stabilizing keratoconus. Saudi J Ophthalmol 2022;36:47-52. https://doi.org/10.4103/sjopt.sjopt_49_22
• 28. Salman A, Ghabra M, Darwish TR, Kailani O, Ibrahim H, Ghabra H. Corneal higher-order aberration changes after accelerated cross-linking for keratoconus. BMC Ophthalmol 2022;22:225. https://doi.org/10.1186/s12886-022-02457-0
• 29. Naderan M, Jahanrad A. Higher-order aberration 4 years after corneal collagen cross-linking. Indian J Ophthalmol 2017;65:808-812. https://doi.org/10.4103/ijo.IJO_21_17
• 30. De Bernardo M, Capasso L, Tortori A, Lanza M, Caliendo L, Rosa N. Trans epithelial corneal collagen crosslinking for progressive keratoconus: 6 months follow up. Cont Lens Anterior Eye 2014;37:438-441. https://doi.org/10.1016/j.clae.2014.07.007